TECTONIC THERAPEUTIC, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
TECTONIC THERAPEUTIC, INC. (TECX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 3.64 million shares as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2024-05-09
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.64M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.67M shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 3.61M shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.18M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2024-03-31 | 3.64M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 3.67M shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 3.61M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 4.18M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 3.86M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 3.07M shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 3.27M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 3.10M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 3.19M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 2.69M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 2.81M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 2.62M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 2.25M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 1.93M shares 10-K · filed 2021-03-18 |
| 2020-09-30 | 1.75M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 1.53M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 1.32M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 977.23K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 790.34K shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 669.89K shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 673.95K shares 10-Q · filed 2019-05-13 |
| 2018-12-31 | 538.21K shares 10-K · filed 2019-03-25 |
| 2018-09-30 | 390.64K shares 10-Q · filed 2018-11-13 |
| 2018-06-30 | 309.59K shares 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |